Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial is investigating subthalamic nucleus targeted transcranial temporal interference stimulation as a treatment for Parkinson's disease; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tang Zhouping | Conditions: Parkinson Disease | NA | Status: NOT_YET_RECRUITING